Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Units will be priced at $0.40 for gross proceeds of up to $2,610,000
  • Research Capital Corporation will act as sole agent and bookrunner
  • BetterLife has granted the agent an over-allotment option to increase the size of the offering by up to 15 per cent
  • The offering is expected to close on or about June 7, 2021, and is pending CSE approval
  • BetterLife Pharma Inc. is an emerging biotechnology company engaged in the development of psychedelic products for the treatment of mental disorders
  • BetterLife Pharma Inc. is up 1.33 per cent, trading at C$0.38 per share at 4:30 pm ET

BetterLife Pharma (BETR) has announced a marketed public offering of units.

Units will be priced at $0.40 for gross proceeds of up to $2,610,000. 

Research Capital Corporation will act as sole agent and bookrunner.

BetterLife has granted the agent an over-allotment option to increase the size of the offering by up to 15 per cent, exercisable at any time and from time to time up to 30 days following the closing of the offering.

Proceeds from the offering will be used for working capital and general corporate purposes.

The offering is expected to close on or about June 7, 2021, and is subject to all necessary regulatory approvals, including the approval of the Canadian Securities Exchange

BetterLife Pharma Inc. is an emerging biotechnology company engaged in the development and commercialization of next-generation psychedelic products for the treatment of mental disorders.

BetterLife Pharma Inc. is up 1.33 per cent, trading at C$0.38 per share at 4:30 pm ET.

More From The Market Herald

" Hemostemix (TSXV:HEM) announces non-brokered private placement

Hemostemix (HEM) has announced a non-brokered private placement of up to 15 million units.
WELL Health - Chairman & CEO Hamed Shahbazi

" WELL Health (TSX:WELL) closes $34.5M public offering

WELL Health Technologies Corp. (WELL) has completed a bought deal public offering for proceeds of $34.5 million.

" Simply Better Brands (TSXV:SBBC) enters the weight loss category

Simply Better Brands (SBBC) has launched its entry into the weight loss category with a PureKana Keto Gummy.

" Cardiol Therapeutics (TSX:CRDL) appoints new directors

Cardiol Therapeutics (CRDL) has appointed Teri Loxam and Chris Waddick to its Board of Directors, effective immediately.